Diagnostic performance of radiologists in distinguishing post-COVID-19 residual abnormalities from interstitial lung abnormalities.

Saved in:
Bibliographic Details
Title: Diagnostic performance of radiologists in distinguishing post-COVID-19 residual abnormalities from interstitial lung abnormalities.
Authors: Lee, Jong Eun1 (AUTHOR), Lee, Hyo-Jae2 (AUTHOR), Park, Gyeryeong2 (AUTHOR), Chae, Kum Ju3 (AUTHOR), Jin, Kwang Nam4 (AUTHOR), Castañer, Eva5 (AUTHOR), Ghaye, Benoit6 (AUTHOR), Ko, Jane P.7 (AUTHOR), Prosch, Helmut8 (AUTHOR), Simpson, Scott9 (AUTHOR), Larici, Anna Rita10 (AUTHOR), Kanne, Jeffrey P.11 (AUTHOR), Frauenfelder, Thomas12 (AUTHOR), Jeong, Yeon Joo13 (AUTHOR), Yoon, Soon Ho14 (AUTHOR) yshoka@snu.ac.kr
Source: European Radiology. Apr2025, Vol. 35 Issue 4, p2265-2274. 10p.
Subjects: Receiver operating characteristic curves, COVID-19, Computed tomography, COVID-19 pandemic, Lung diseases
Abstract: Objective: Distinguishing post-COVID-19 residual abnormalities from interstitial lung abnormalities (ILA) on CT can be challenging if clinical information is limited. This study aimed to evaluate the diagnostic performance of radiologists in distinguishing post-COVID-19 residual abnormalities from ILA. Methods: This multi-reader, multi-case study included 60 age- and sex-matched subjects with chest CT scans. There were 40 cases of ILA (20 fibrotic and 20 non-fibrotic) and 20 cases of post-COVID-19 residual abnormalities. Fifteen radiologists from multiple nations with varying levels of experience independently rated suspicion scores on a 5-point scale to distinguish post-COVID-19 residual abnormalities from fibrotic ILA or non-fibrotic ILA. Interobserver agreement was assessed using the weighted κ value, and the scores of individual readers were compared with the consensus of all readers. Receiver operating characteristic curve analysis was conducted to evaluate the diagnostic performance of suspicion scores for distinguishing post-COVID-19 residual abnormalities from ILA and for differentiating post-COVID-19 residual abnormalities from both fibrotic and non-fibrotic ILA. Results: Radiologists' diagnostic performance for distinguishing post-COVID-19 residual abnormalities from ILA was good (area under the receiver operating characteristic curve (AUC) range, 0.67–0.92; median AUC, 0.85) with moderate agreement (κ = 0.56). The diagnostic performance for distinguishing post-COVID-19 residual abnormalities from non-fibrotic ILA was lower than that from fibrotic ILA (median AUC = 0.89 vs. AUC = 0.80, p = 0.003). Conclusion: Radiologists demonstrated good diagnostic performance and moderate agreement in distinguishing post-COVID-19 residual abnormalities from ILA, but careful attention is needed to avoid misdiagnosing them as non-fibrotic ILA. Key Points: QuestionHow good are radiologists at differentiating interstitial lung abnormalities (ILA) from changes related to COVID-19 infection? FindingsRadiologists had a median AUC of 0.85 in distinguishing post-COVID-19 abnormalities from ILA with moderate agreement (κ = 0.56). Clinical relevanceRadiologists showed good diagnostic performance and moderate agreement in distinguishing post-COVID-19 residual abnormalities from ILA; nonetheless, caution is needed in distinguishing residual abnormalities from non-fibrotic ILA. [ABSTRACT FROM AUTHOR]
Copyright of European Radiology is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Engineering Source
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first